A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
for Solid Tumor
Sites in Nashville +14 more locations
Sponsor: NiKang Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06586957·Phase 1·Recruiting·Listed Sep 2024
GI oncology Clinical Trials in Nashville, TN
As of August 2026, 77 paid clinical trials are recruiting for GI oncology in Nashville, Tennessee. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
78 clinical trials for GI oncology
·Clear filters· Email me when a new gi oncology trial opens in Nashville, TN.
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
for Pancreatic Ductal Adenocarcinoma
Sites in Nashville +12 more locations
Sponsor: Verastem, Inc.
Sex: All·Age: 18+
Code: NCT07020221·Phase 1, Phase 2·Recruiting·Listed Jun 2025
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
for Advanced Solid Tumor
Sites in Nashville +20 more locations
Sponsor: Clasp Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06778863·Phase 1·Recruiting·Listed Jan 2025
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
for Non Small Cell Lung Cancer
Sites in Nashville +23 more locations
Sponsor: SystImmune Inc.
Sex: All·Age: 18+
Code: NCT05983432·Phase 1·Recruiting·Listed Aug 2023
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
for Head and Neck Squamous Cell Carcinoma
Sites in Nashville +14 more locations
Sponsor: Bicara Therapeutics
Sex: All·Age: 18+
Code: NCT04429542·Phase 1·Recruiting·Listed Jun 2020
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
for Brain Cancer
Sites in Nashville, Memphis +14 more locations
Sponsor: Adela, Inc
Sex: All·Age: 40+·Accepts healthy volunteers
Code: NCT05366881·Recruiting·Listed May 2022
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
for Metastatic Colorectal Cancer
Drug: Bevacizumab
Sites in Nashville +17 more locations
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All·Age: 18+
Code: NCT07549412·Phase 3·Recruiting·Listed Apr 2026
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
for Non-Small-Cell Lung
Sites in Nashville +10 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07519655·Phase 1·Recruiting·Listed Apr 2026
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
for Colorectal Cancer
Sites in Nashville +2 more locations
Sponsor: Dispatch Biotherapeutics
Sex: All·Age: 18+
Code: NCT07544589·Phase 1·Recruiting·Listed Apr 2026
A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors
for Colorectal Neoplasms
Sites in Nashville +3 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07107230·Phase 1·Recruiting·Listed Aug 2025
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
for Advanced Solid Tumors
Sites in Nashville +14 more locations
Sponsor: Vividion Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06004245·Phase 1·Recruiting·Listed Aug 2023
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
for Diffuse Astrocytoma, IDH-Mutant
Sites in Nashville +6 more locations
Sponsor: Neonc Technologies, Inc.
Sex: All·Age: 18+
Code: NCT06047379·Phase 1, Phase 2·Recruiting·Listed Sep 2023
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
for Advanced Malignant Solid Neoplasm
Sites in Nashville +2 more locations
Sponsor: RasCal Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT04678648·Phase 1·Recruiting·Listed Dec 2020
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
for Non Small Cell Lung Cancer
Sites in Nashville +4 more locations
Sponsor: Phanes Therapeutics
Sex: All·Age: 18+
Code: NCT05431270·Phase 1, Phase 2·Recruiting·Listed Jun 2022
CT-95 in Advanced Cancers Associated With Mesothelin Expression
for Mesothelin-Expressing Tumors
Sites in Nashville +8 more locations
Sponsor: Context Therapeutics Inc.
Sex: All·Age: 18+
Code: NCT06756035·Phase 1·Recruiting·Listed Jan 2025
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
for Biliary Tract Cancer
Sites in Nashville +5 more locations
Sponsor: ModeX Therapeutics, An OPKO Health Company
Sex: All·Age: 18+
Code: NCT06239194·Phase 1, Phase 2·Recruiting·Listed Feb 2024
IKS014 in Advanced Solid Tumors That Express HER2
for Breast Cancer
Sites in Nashville +3 more locations
Sponsor: Iksuda Therapeutics Ltd.
Sex: All·Age: 18+
Code: NCT05872295·Phase 1·Recruiting·Listed May 2023
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
for Colorectal Cancer
Sites in Nashville +8 more locations
Sponsor: Criterium, Inc.
Sex: All·Age: 18+
Code: NCT06992258·Phase 2·Recruiting·Listed May 2025
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
for Cancer
Sites in Nashville +5 more locations
Sponsor: Angiex, Inc.
Sex: All·Age: 18+
Code: NCT06440005·Phase 1·Recruiting·Listed Jun 2024
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
for Lung Cancer (NSCLC)
Sites in Nashville +2 more locations
Sponsor: Phrontline Biopharma
Sex: All·Age: 18+
Code: NCT07181473·Phase 1·Recruiting·Listed Sep 2025
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
for Advanced Malignant Neoplasm
Sites in Nashville +3 more locations
Sponsor: AtlasMedx, Incorporated
Sex: All·Age: 18+
Code: NCT04503265·Phase 1, Phase 2·Recruiting·Listed Aug 2020
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
for Neuroendocrine Tumors
Sites in Nashville +3 more locations
Sponsor: Chimeric Therapeutics
Sex: All·Age: 18 - 85
Code: NCT06055439·Phase 1, Phase 2·Recruiting·Listed Sep 2023
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
for Gastric Adenocarcinoma
Sites in Nashville +77 more locations
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All·Age: 18+
Code: NCT07001748·Phase 2, Phase 3·Recruiting·Listed Jun 2025
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
for Colon Cancer
Sites in Nashville +13 more locations
Sponsor: SCRI Development Innovations, LLC
Sex: All·Age: 18+
Code: NCT07011576·Phase 2·Recruiting·Listed Jun 2025
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
for Rectal Cancer
Sites in Nashville, Germantown +101 more locations
Sponsor: Canadian Cancer Trials Group
Sex: All·Age: 18+
Code: NCT06205485·Phase 3·Recruiting·Listed Jan 2024
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
for Non-small Cell Lung Cancer
Sites in Nashville +19 more locations
Sponsor: Institut de Recherches Internationales Servier
Sex: All·Age: 18+
Code: NCT05786924·Phase 1, Phase 2·Recruiting·Listed Mar 2023
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
for Colorectal Cancer
2 locations in Nashville
Sponsor: Vanderbilt University Medical Center
Sex: All·Age: 18+
Code: NCT00899626·Recruiting·Listed May 2009
Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response
for Pancreatic Cancer
Sites in Nashville +1 more location
Sponsor: Ohio State University
Sex: All·Age: 19+
Code: NCT04588025·Recruiting·Listed Oct 2020
Preserving Fertility After Colorectal Cancer Study
for Colorectal Cancer
1 location in Nashville
Sponsor: Andreana Holowatyj, PhD, MSCI
Sex: All·Age: 18 - 49
Code: NCT05239338·Recruiting·Listed Feb 2022
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
for Gastric Cancer
Drug: Sonesitatug vedotin
Sites in Nashville +71 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT07431281·Phase 3·Recruiting·Listed Feb 2026
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
for HNSCC
Sites in Nashville +17 more locations
Sponsor: Normunity AccelCo, Inc.
Sex: All·Age: 18+
Code: NCT07182149·Phase 1·Recruiting·Listed Sep 2025
DESTINY-PANTUMOUR04
for Adenocarcinoma (NOS)
Sites in Nashville +17 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18 - 130
Code: NCT07124000·Recruiting·Listed Aug 2025
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
for Non-small Cell Lung Cancer
Sites in Nashville +17 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT06218914·Phase 1·Recruiting·Listed Jan 2024
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
for Metastatic Colorectal Cancer
Sites in Nashville +10 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18 - 130
Code: NCT06792695·Phase 2·Recruiting·Listed Jan 2025
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
for Endometrial Cancer
Sites in Nashville +10 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18 - 130
Code: NCT05489211·Phase 2·Recruiting·Listed Aug 2022
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
for Non-small Cell Lung Cancer
Sites in Nashville +13 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT05877599·Phase 1·Recruiting·Listed May 2023
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
for Advanced Solid Tumor
Sites in Nashville +7 more locations
Sponsor: MOMA Therapeutics
Sex: All·Age: 18+
Code: NCT06545942·Phase 1·Recruiting·Listed Aug 2024